This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sunshine Lake Pharma Co., Ltd.. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Shun Li: Innovator in Pharmaceutical Chemistry
Introduction
Shun Li is a prominent inventor based in Dongguan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of intermediates for drug synthesis. With a total of 2 patents to his name, Shun Li is recognized for his innovative approaches to chemical processes.
Latest Patents
One of Shun Li's latest patents is focused on a sacubitril intermediate and its preparation method. This invention relates to a sacubitril intermediate that can be synthesized through a deprotection reaction of a compound. The disclosed intermediate serves as a raw material for synthesizing sacubitril, a medication used in treating heart failure. The method outlined in the patent boasts several advantages, including the use of easily obtainable raw materials, a simple preparation process, low cost, and environmental friendliness, making it highly suitable for industrial production.
Career Highlights
Shun Li is currently employed at Sunshine Lake Pharma Co., Ltd., where he continues to advance his research and development efforts. His work has not only contributed to the company's portfolio but has also had a broader impact on the pharmaceutical industry.
Collaborations
Shun Li collaborates with talented colleagues, including Xiaodong Han and Zhongqing Wang. Their combined expertise fosters a productive environment for innovation and development in pharmaceutical chemistry.
Conclusion
Shun Li's contributions to the field of pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the industry. His work continues to pave the way for advancements in drug synthesis and production methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile